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Abstract
Biofilm is an important virulence factor in Pseudomonas aeruginosa and has a substantial
role in antibiotic resistance and chronic burn wound infections. New therapeutic agents
against P. aeruginosa, degrading biofilms in burn wounds and improving the efficacy of cur-
rent antimicrobial agents, are required. In this study, the effects of α-mannosidase, β-man-
nosidase and trypsin enzymes on the degradation of P. aeruginosa biofilms and on the
reduction of ceftazidime minimum biofilm eliminating concentrations (MBEC) were evalu-
ated. All tested enzymes, destroyed the biofilms and reduced the ceftazidime MBECs.
However, only trypsin had no cytotoxic effect on A-431 human epidermoid carcinoma cell
lines. In conclusion, since trypsin had better features than mannosidase enzymes, it can be
a promising agent in combatting P. aeruginosa burn wound infections.
Introduction
Burn wound infections are one of the most important complications that occur after burn inju-
ries and may be associated with serious clinical complications and increasedmorbidity and
mortality [1, 2]. Pseudomonas aeruginosa is one of the most important pathogens involved in
burn infections [1]. The emergence of multidrug-resistant P. aeruginosa infections is the major
concern with managing P. aeruginosa burn infections as it is very difficult to treat [3]. P. aerugi-
nosa alters the expression of its virulence factors in wound infections [2], including the produc-
tion of biofilm in burn wounds [4]. Such hospital-acquired infections delayed healing for 2 to 4
weeks [5]. The biofilmmediates bacterial stability and protects them from surrounding envi-
ronment, such as the immune system and increases the antibiotic resistance [6].
The biofilmmatrix in P. aeruginosa is composed of three distinct exopolysaccharides: algi-
nate, Psl and Pel. Alginate is a polymer consisting of β-D-mannuronic acid and α-L-guluronic
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acid and has a substantial role in structural stability and protection of biofilm. Psl is a polysac-
charide composed of a repeating pentasaccharide, consisting of D-mannose, D-glucose and L-
rhamnose. Psl is important in the initiation of biofilm formation and protection of biofilm
structure. Pel is the third polysaccharide which is present in P. aeruginosa biofilm and is glu-
cose-rich [7]. Additionally, a lot of surface proteins are involved in P. aeruginosa biofilm for-
mation [8].
Due to the increasing P. aeruginosa antibiotic resistance and given the importance of biofilm
in increasing the antimicrobial resistance, researchers are exploring novel therapeutic strategies
targeting biofilms. This may contribute to improve the treatment of biofilm-related infections
[9]. Some of the anti-biofilmmethods that have been studied in recent years include: small
molecule based inhibitors, phytochemicals, bacteriophage therapy, photodynamic therapy,
antimicrobial peptides, monoclonal antibodies, nanoparticles and biofilm degrading enzymes
[10–13].
The α-mannosidase enzyme is an acid hydrolase which is located in plant vacuoles and is
thought to be involved with the turnover of N-linked glycoproteins and has been purified from
Canavalia ensiformis (Jack bean) [14]. The β-mannosidase enzyme was purified from helix
pomatia and hydrolyzes the terminal mannose residues, which are β-1!4 linked to oligosac-
charides or glycopeptides [15]. Based on the structure of Psl polysaccharide and due to the per-
formance features of mannosidase enzymes, it was assumed that these enzymes may destroy
Psl polysaccharide.
Trypsin is a pancreatic serine endoprotease that cleaves proteins or peptides on the carboxyl
side of arginine (R) or lysine (K) residues [16]. It was supposed that trypsin enzymemay
destroy protein contents of the biofilmmatrix in P.aeruginosa.
In the current study, we investigate the effects of mannosidase and trypsin enzymes on the
degradation of biofilms of P. aeruginosa strains that were isolated from burn wound infections.
Material and Methods
Bacterial strains
A total number of 57 P. aeruginosa isolates were collected from infections in burn wound
patients from ShahidMotahari Hospital of Iran University of Medical Sciences, during October
2013 throughMarch 2014. The identity of the isolates were determinedwith by conventional
biochemical tests including Gram stain, oxidase, catalase, oxidation-fermentation (OF) test
and the Kligler Iron Agar (KIA) tests [17].
Ethics Statement
The Central Laboratory from Shahid Motahari Hospital provided the P. aeruginosa isolates for
this study. The clinical information presented in this manuscript was obtained from the
patient’s medical record, considering the sample type. The study protocol was approved by the
Ethics Committee of Tehran University of Medical Sciences (No 25137).
Antibiotic Susceptibility Testing
Susceptibility of isolates to various antibiotics was determined by Disk DiffusionAgar and
Broth microdilutionmethods as recommended by the Clinical and Laboratory Standards Insti-
tute (CLSI) [18].
The following antibiotic disks (Mast Diagnostics-UK), were tested: Amikacin (AK), Genta-
micin (GM), Meropenem (MEM), Imipenem (IMI), Ceftazidime (CAZ), Cefepime (CMP) and
Polymixine B (PB). Escherichia coli ATCC 25922 was used as a control for susceptibility testing.
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The MICs of Amikacin (Sigma Aldrich, St Louis, USA) and Ceftazidime (Jaber Ebne Hay-
yan Co, Iran) were determined by CLSI broth microdilutionmethod (MIC range,0.5 to
256 μg/ml). P. aeruginosa ATCC 27853 were used as a control for quality assurance of the test.
Detection of genes encoding biofilm exopolysaccharides
The genes encoding biofilm exopolysaccharides (algD, pelF and pslD) were targeted by a PCR-
basedmethod, using primers listed in Table 1 [17]. The following protocol was used for PCR
procedure. DNA extractionwas performed by boilingmethod. Each 12.5 μL reaction contains:
2.5 μL of DNA, 5 μL of Taq 2× Master Mix (Ampliqon, Denmark), 0.25 μL of each forward
and reverse primers with the concentration of 10 pmol/μL and 4.5 μL of distilledwater. PCR
was performed under the following conditions: initial denaturation for 5 min at 95°C, then
denaturation for 1 min at 95°C, 30 cycles of 40 s at 58°C (for algD, pelF and pslB genes), and
56°C (for pslD gene), 45 second at 72°C, and a final elongation step for 5 min at 72°C. PCR
products were analyzed with UV light after running at 120V for 45 minute on a 1% agarose gel.
Biofilm assay
P.aeruginosa isolates were inoculated in 5ml trypticase soy broth (TSB) (Gibco, USA) and incu-
bated for 24 h at 37°C, then they were diluted in TSB to a turbidity equal to 0.5 McFarland
standard and each well of a flat-bottomed polystyrene 96-well microtiter plate (Tissue culture
plate 96 wells, JET BIOFIL, Canada) were inoculatedwith 100 μL of these dilutions. Pseudomo-
nas aeruginosa ATCC 27853 and sterile broth were used as positive and negative control. After
24 h incubation at 37°C, the supernatant (containing non-adherent cells) was removed and
wells were rinsed with normal saline solution (0.90% w/v of NaCl) three times. Biofilms were
fixed by 96% ethanol, and then stained with crystal violet (1.5% w/v) for 20 minute, after that
unbound stain was removed by washing with tap water. The dye was solubilized in 150 μL of
33% (v/v) acetic acid. The optical densities (OD) of the wells were determined by using a
microplate reader (Anthos Labtec instruments, type: 22550) set to 550 nm [17]. All assays were
performed in triplicate and repeated three times for each strain.
Three standard deviations above the mean absorbance of negative control were considered as
cut-off OD (ODC). Biofilm formation was categorized by the following formulas: If OD<ODc,
the biofilmwas not formed (negative), If ODc<OD< 2xODc, the biofilmwas weak, If
2xODc<OD< 4xODc, the biofilmwas moderate. If 4xODc<OD, the biofilmwas strong.
Based on sensitivity to amikacin and ceftazidime, biofilm production and genotypic charac-
teristics, isolates were selected for further studies.
Enzymatic assay
The biofilm detachment assay was performed as describedpreviously [11]. Briefly, after the
establishment of biofilms in the wells of a flat-bottomed polystyrene 96-well microtiter plate
Table 1. Primers used for the amplification of the genes coding for biofilm exopolysaccharides among Pseudomonas aeruginosa isolates.
Gene primer sequence (5’!3’) Annealing temperature (˚C) Size of amplicon (bp)
algD F-CTACATCGAGACCGTCTGCC 58 593
R-GCATCAACGAACCGAGCATC
pelF F-GAGGTCAGCTACATCCGTCG 58 789
R-TCATGCAATCTCCGTGGCTT
pslD F- TGTACACCGTGCTCAACGAC 56 369
R- CTTCCGGCCCGATCTTCATC
doi:10.1371/journal.pone.0164622.t001
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(Tissue culture plate 96 wells, JET BIOFIL, Canada), biofilms were incubated with different
concentrations of enzymes (α-mannosidase and β-mannosidase enzyme concentrations: 0.005,
0.01, 0.015, 0.02 and 0.03 unit/ml and trypsin enzyme concentrations: 0.08, 0.175, 0.35, 0.75
and 1.5 μg/ml), the optimal concentration of each enzyme was selected and used for incubation
with biofilms for 1h at 37°C.Well content was removed and washed thrice with sterile saline
solution (NaCl, 0.9% w/v) and were stained using the CV assay. The optical densities (OD) of
the biofilms were determined at 550 nm by using a microplate reader (Anthos Labtec instru-
ments, type: 22550). Biofilms with no enzyme treatment was used as a positive control and
mediumwithout bacteria and enzyme was used as a negative control. The test was performed
once with three replications. All enzymes were purchased from Sigma Aldrich (St Louis, USA).
Since α-mannosidase and β-mannosidase enzymes used similar buffer conditions, their
combined effects on P. aeruginosa biofilm production was analyzed as well. This test was car-
ried out once with three replications.
The bactericidal effect of the enzymes on planktonic cells of P. aeruginosa was evaluated.
Firstly, 50 μL of Mueller—Hinton broth (Merck, Germany) was added to each microtiter plate
well (Tissue culture plate 96 wells, JET BIOFIL, Canada) and subsequently, 50 μL of bacterial
suspension with a final inoculumdensity of 108 CFU/ml was added to each well and was mixed
with α-mannosidase, β-mannosidase and Trypsin. The microtiter- plate was incubated for 20h
at 37°C, and the effect of enzymes on the bacterial growth was determinedwith respect to well
described turbidity. After evaluating the turbidity in the wells, 20 μL of the suspension with no
turbidity was inoculated on the TSAmedia and incubated,and then presence of colonies was
checked, This test was performed 3 times.
Determination of the Minimum Biofilm Eliminating Concentrations
(MBECs)
The MBECs of bacterial biofilm cultures for amikacin and ceftazidimewere determined
according to the method of Amorena et al using the XTT (2,3-bis[2-methyloxy-4-nitro-5-sul-
fophenyl]-2H-tetrazolium-5-carboxanilide) colorimetric assay with somemodifications [19].
Briefly, biofilms were established in the wells of a flat-bottomed polystyrene 96-well microtiter
plate (Tissue culture plate 96 wells, JET BIOFIL, Canada). After incubation of bacterial biofilms
with 100 μL of serial dilutions of antibiotics at 37°C for 20 h, 50 μL of fresh XTT labeling mix-
ture (Roche, Germany) was added to each well and subsequently incubated for 1 h at 37°C in
the dark conditions [20]. The lowest concentration of the antibiotic that inhibited re-growth of
the bacteria from the treated biofilmwas defined as the MBEC value [21]. This test was con-
ducted 3 times. This experiment was performed on 3 strains 1, 2 and 4, because they were sus-
ceptible to ceftazidime and amikacin in planktonic state, but strain 3 that was resistant to
amikacin and strain 5 that was resistant to both amikacin and ceftazidime,were not involved
in the experiment.
The combined effect of enzymes and ceftazidime on P. aeruginosa
biofilms
The combined effect of enzymes and ceftazidime on P. aeruginosa biofilms was determined as
describedpreviously [22, 23]. Briefly, bacterial biofilms with either 100 μL of ceftazidime or
ceftazidimewith enzyme; α-mannosidase and β-mannosidase (0.02 unit/ml) or trypsin
(0.75 μg/ml) were incubated at 37°C for 20 h. Subsequently, the well content was removed and
washed with normal saline. The MBEC values of ceftazidime for biofilm cultures were deter-
mined using the XTT reduction assay. This test was performed 3 times.
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Cytotoxicity assay
Cell line preparation and cytotoxicity assays were performed as described by Braydich-Stolle
et al [21]. Briefly, A-431 human epidermoid carcinoma cell lines (NCBI Code: C204) were
maintained in RPMI 1640 medium (Biosera, USA) supplemented with 10% heat inactivated
fetal bovine serum (FBS), 2mM L-glutamine, 50 u/ml penicillin and 50 mg/ml streptomycin.
For morphological and viability studies, cells were seeded at a concentration of 5× 104 cells/
well in 100 μL of complete medium into 96-well plates and were incubated for 24h in a humidi-
fied atmosphere at 37°C and 6.5% CO2.
After 24h, when cells reached 60% confluency, selected concentrations of enzymes were
added to the wells. To evaluate the cytotoxic effect of enzymes, morphological changes in cells
were assessed by invert microscopy (Olympus 1x70, USA) every hour for the first 4 hours and
finally after 24h.
Mitochondrial functions of the cells were evaluated by XTT reduction assay. After 24h
exposing to the enzymes, specific amounts of XTT labeling mixture was directly added to the
culture wells and after 4h incubation in the dark conditions, the absorbance at 492 nm was
measured using a microplate reader (Anthos Labtec instruments, type: 22550).
In the present experiment, the positive control consisted of cells without enzyme exposure
and for the negative control, sterile mediumwas used. The relative cell viability (%) was com-
puted by this formula: [A]test/[A]control ×100, in which [A]test is the absorbance of the test sam-
ple and [A]control is the absorbance of the control positive sample [24]. This test was performed
2 times in duplicates.
Statistical analysis
Based on normal distribution of variables [i.e. ODs of biofilms before (OD B) and after (ODA)
enzyme treatment and their differences (OD B-A)], non-parametric tests such as Wilcoxon
Signed Ranks test and Paired-Samples T Test were used for comparison of ODs before and
after treatment with enzymes and One- way ANOVA test was used for determination the
effects of enzymes on different P.aeruginosa strains. A Kruskal-Wallis test was applied to study
the effects of combination of mannosidase enzymes on the biofilms of strains. The differences
between ceftazidimeMBECs before and after using enzymes were evaluated by Mann-Whitney
U test for each strain. A One- way ANOVA test was used for comparing viability (%) of the
cells after enzyme assay. A P value<0.05 was considered statistically significant. All tests were
performed using online available GraphPad software (http://www.graphpad.com).
Results
The antimicrobial resistance of 57 P.aeruginosa isolates to amikacin (AK), gentamicin (GM),
cefepime (CPM), ceftazidime (CAZ), Imipenem (IMP), meropenem (MEM) and polimyxine B
(PB) were determined by disk diffusion agar method and results are listed in Table 2. The high-
est resistance rate was observed against CPM and GM (94.7%) and the lowest resistance rate
was seen against PB (0%).
The frequency of genes encoding biofilm exopolysaccharides among 57 P.aeruginosa strains
was as follows: pelF (93%), pslD (54.65%) and algD (100%). Based on the presence of these
genes, 4 genotypic patterns were found, which pelF+, algD+, pslD+ was the most frequent pat-
tern and 30 strains (52.63%) had this genotype and pelF-, algD+, pslD- had the lowest frequency
and only 2 strains (3.5%) showed this genotype (Table 3).
The results of microtiter plate assay demonstrated that 55 strains (96.5%) were biofilm pro-
ducers in which 30.9% of them produced strong biofilms, 47.3% producedmedium biofilms
and 21.8% of formed weak biofilms. Only 2 strains (3.5%) were non-producers.
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The genotypic and phenotypic characteristics of 5 P. aeruginosa isolates that were selected
out of 57 strains were presented in Table 4. Isolates had ability to produce moderate or strong
biofilms and all of them were susceptible to polymixine B.
From the results of a single experiment, it was concluded that α-mannosidase, 03B2-man-
nosidase and trypsin enzymes reduced the ODs of the biofilms (P<0.05) (Fig 1). The most
effective concentrations of α -mannosidase, β-mannosidase and trypsin enzymes on biofilms
were 0.02 units/ml, 0.02 units/ml and 0.75 μg/ml, respectively (Fig 2). There were no significant
differences between the effects of combinations of mannosidase enzymes with effects of each
enzyme alone (P>0.05) and in both cases, the enzymes detached the biofilms (Fig 3). The β-
mannosidase had no bactericidal effect, but α-mannosidase and trypsinwere toxic and all
tested concentrations killed bacterial cells and no turbidity was seen in the wells and no colo-
nies were present.
The MBEC results for bacterial biofilm are listed in Table 5. All three strains were resistant
to ceftazidime in biofilm; however these strains were susceptible to this agent in planktonic
state (Table 4).
Table 2. Antibiotic susceptibility of the P.aeruginosa isolates by disk diffusion method.
Antimicrobial agent Isolates, N (%)
Susceptible Intermediate Resistant
Amikacin 4 (7) 0 53 (93)
Gentamicin 3 (5.3) 0 54 (94.7)
Cefepime 3 (5.3) 0 54 (94.7)
Ceftazidime 22 (38.6) 0 35 (61.4)
Imipenem 5 (8.8) 3 (5.2) 49 (86)
Meropenem 4 (7) 0 53 (93)
Polymixine B 57 (100) 0 0
doi:10.1371/journal.pone.0164622.t002
Table 3. Relative frequency of the genotypic patterns among P.aeruginosa isolates.
Genotypic pattern Isolates, N (%)
pelF+, algD+, pslD+ 30 (52.63)
pelF-, algD+, pslD+ 3 (5.26)
pelF+, algD+, pslD- 22 (38.6)
pelF-, algD+, pslD- 2 (3.5)
doi:10.1371/journal.pone.0164622.t003
Table 4. Phenotypic and genotypic characteristics of P. aeruginosa strains were evaluated in this study.
Strain Resistance Pattern MIC (μg/ml) Genotypic pattern Biofilm
AK GM CAZ CPM IMI MEM PB AK CAZ
1 S S S R S S S 4 2 pelf+ psld + algd+ Strong
2 S S S S S S S 4 2 pelf + psld + algd+ Strong
3 R R S R R R S 256 4 pelf—psld + algd+ Moderate
4 S S S S S S S 8 2 pelf + psld—algd+ Strong
5 R R R R R R S >256 >256 pelf—psld—algd+ Moderate
AK, amikacin; GM, gentamicin; CAZ, ceftazidime; CPM, cefepime; IMI, imipenem; MEM, meropenem; PB, polymixine B; S, sensitive; R, resistant; MIC,
minimum inhibitory concentration.
doi:10.1371/journal.pone.0164622.t004
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The combination of enzymes and ceftazidime significantly decreased the ceftazidime
MBECs (P<0.05) (Table 6). Biofilm did not affect the susceptibility of strains to amikacin and
remained susceptible to this antibiotic.
The morphology of the A-431 human epidermoid carcinoma cell lines after 24h incubation
with trypsin enzyme had no changes compared to control cells (Fig 4) and trypsin enzyme had
no significant effect on mitochondrial activity and cell viability, however the cytotoxic effect of
mannosidase enzymes were high and reduced the mitochondrial function of the cells (Fig 5).
Fig 1. The effects of serial dilutions of alpha-mannosidase (A), beta-mannosidase (B) and trypsin (C)
enzymes on the biofilm of P.aeruginosa strain 3. The experiment was done once in triplicates. Error bars
represent standard errors.
doi:10.1371/journal.pone.0164622.g001
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Discussion
P. aeruginosa is one of the causes of serious infections in burn patients and emergence of multi-
drug resistant (MDR) isolates of P.aeruginosa in the burn units is an important problem in
controlling its infections [25].
In our study, more than 90% of the isolates were resistant to amikacin, gentamicin, cefepime
and meropenem and the rate of resistance to ceftazidime and Imipenem were 61% and 83%,
Fig 2. The effect of selected concentration of enzymes alpha-mannosidase, beta-mannosidase, and trypsin
on the biofilms of P. aeruginosa isolates. The experiment was performed once in triplicates. Error bars represent
standard errors.
doi:10.1371/journal.pone.0164622.g002
Fig 3. The effects of combinations ofalpha-mannosidase and beta-mannosidase enzymes on the
biofilm of P. aeruginosa strain 3. alpha- mannosidase and beta- mannosidase enzymes were used at the
concentration of 0.02 unit/ml. Combination1: The wells were treated with 0.02 unit/ml of enzyme alpha-
mannosidase and then after 1h were treated with the same concentration of enzyme beta- mannosidase.
Combination 2: The wells were treated with 0.02 unit/ml of enzyme beta- mannosidase and then after 1h
were treated with the same concentration of enzyme alpha-mannosidase. The test was conducted once in
triplicates. Error bars represent standard errors.
doi:10.1371/journal.pone.0164622.g003
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respectively. In overall, 87% of the isolates were MDR. In a study conducted by Anvarinejad
et al., [26], resistance level to the amikacin, gentamicin, cefepime and meropenemwere similar
to our study, however resistance to ceftazidime and imipenemwere higher than our study
(72% and 98%, respectively). Nikokar et al., reportedmuch lower resistance rate for imipenem,
gentamicin and amikacin and 42.3% of their isolates were MDR, which was lower than our
study [27]. Probably, discrepancies in the antimicrobial resistance levels in various studies are
related to the differences in the patterns of antibiotic consumption in different areas. Therefore,
appropriate therapeutic regimen for treatment of P.aeruginosa infections should be selected
based on the location of bacterial isolation.
According to the results, 98.4% of the isolates formed biofilm that was similar to the results
of Vasiljević et al., [28] and Jabalameli et al., [17], Which reflects the importance of biofilm
Table 5. Minimum Biofilm Eliminating Concentrations (MBECs) results for P. aeruginosa strains iso-
lated from burn wound infections.
Strain Amikacin (μg/ml) Ceftazidime (μg/ml)
1 16 1024
2 16 1024
4 8 1024
doi:10.1371/journal.pone.0164622.t005
Table 6. The combined effects of enzymes and ceftazidime on the MBEC values of ceftazidime.
Strain Ceftazidime
(μg/ml)
CAZ+ α-mannosidase
(μg/ml)
CAZ + β-mannosidase
(μg/ml)
CAZ + trypsin
(μg/ml)
1 1024 128 128 512
2 1024 4 4 8
4 1024 4 8 32
CAZ, Ceftazidime.
doi:10.1371/journal.pone.0164622.t006
Fig 4. Morphology of the A-431 human epidermoid carcinoma cell lines after 24h incubation with
alpha-mannosidase, beta-mannosidase and trypsin enzymes. A. alpha-mannosidase (0.02 unit/ml). B.
beta-mannosidase (0.02 unit/ml). C. citrate buffer)100mM, pH 4.5). D. trypsin (0.75 μg/ml). E. Control
positive (cells with no enzyme treatment). The experiment was performed 2 times in duplicates.
doi:10.1371/journal.pone.0164622.g004
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formation by P.aeruginosa in burn wounds and it can be considered as one of the causes of
delaying the treatment of burn patients.
The prevalence of algD in our study was 100% and was high compared with the results of
Zaranza et al., and Ghadaksaz et al., which have reported a prevalence rate of 39% and 87.5%,
respectively [29, 30]. It is possible that the differences observed in the prevalence of this gene
are because of different prevalent clones in each region. There is no prevalence rate about pslD
and pelF genes in other regions, but studies demonstrate that pel gene cluster are conserved
among isolates of P.aeruginosa, however psl genes are not present in all isolates [31], which is
in agreement with our results.
In recent years, enzymatic debriding agents such as collagenase and Papain-urea are using
in burn wound treatment because of their effects on collagen, elastin and fibrin that remove
necrotic tissues and accelerate wound healing [32]. Regular debridement also eliminates some
parts of the biofilm EPS and force the remaining bacteria to return to the state that they are
metabolically active, so the antibiotics and antiseptic compounds would be more effective. In
addition, the use of anti-biofilm compounds can help to eliminate biofilms from the wound
bed or weaken the matrix and disintegrate the biofilm [5].
As is clear in Fig 2, bothmannosidase enzymes were effective and degraded the biofilms of P.
aeruginosa strains with various genotypic patterns and altered the state of biofilms from strong
to the moderate or negative. Biofilm of strain 5 with genotypic pattern of pelF-, algD+, pslD- was
not affected (P>0.05). These results may suggest that mannosidase enzymes do not have any
effect on the structure of alginate, since alginate does not have any mannose residues in its struc-
ture. The mannosidase enzymes also had same effects on ceftazidimeMBECs and reduced sig-
nificantly. The results of toxicity assay indicated that mannosidase enzymes cause changes in
cell morphology and reduce the mitochondrial activity of the cells, and are cytotoxic.
According to our results (Fig 2), the trypsin also destroyed the P. aeruginosa biofilm; how-
ever its effect was weaker than mannosidase enzymes. These results may not be due to the poor
effect of this enzyme but it may contribute to the fewer protein contents of P. aeruginosa
Fig 5. Influence of the most effective concentrations of alpha-mannosidase (0.02 unit/ml), beta-
mannosidase (0.02 unit/ml), citrate buffer (100mM, pH 4.5) and trypsin (0.75μg/ml) on the viability of
A-431 human epidermoid carcinoma cell lines after 24h incubation. No enzyme column represents
control positive of the test. The relative cell viability (%) was computed by this formula: [A]test/ [A]control ×100.
The experiment was performed 2 times in duplicates. Error bars represent standard errors.
doi:10.1371/journal.pone.0164622.g005
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biofilm rather than polysaccharides, since proteins are one of the sub components of biofilm in
this bacterium [7]. Trypsin also decreased the ceftazidimeMBECs significantly as a result of
both enzymatic biofilm degradation and its bactericidal effect. The trypsin did not change the
morphology or mitochondrial functions of the cells indicating its non-toxicity.
In conclusion, our finding (Fig 2) demonstrated that trypsin enzyme can be a good candi-
date for future studies in the field of antibiofilm agents, because it could destroy biofilms of P.
aeruginosa burn isolates and result in decreased ceftazidimeMBECs with no toxic side effects.
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